Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
2021 · The Lancet Oncology · 282 citations
https://doi.org/10.1016/s1470-2045(21)00493-9
S
Stuart McIntosh
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
309
Papers
4.1K
Citations
35
h-index
70
i10-index
Stuart McIntosh is an academic researcher from Opsona Therapeutics (Ireland). The author has contributed to research in topics: Breast Cancer Treatment Studies & Advanced Breast Cancer Therapies & HER2/EGFR in Cancer Research. The author has an h-index of 35, co-authored 263 publications.
ORCID: 0000-0002-4123-9611Papers by this author
worksRandomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET Trial
2018 · Journal of Clinical Oncology · 224 citations
https://doi.org/10.1200/jco.18.01624
Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study
2019 · The Lancet Oncology · 188 citations
https://doi.org/10.1016/s1470-2045(18)30781-2
The Lancet Breast Cancer Commission
2024 · The Lancet · 132 citations
https://doi.org/10.1016/s0140-6736(24)00747-5
Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study
2022 · American Journal of Obstetrics and Gynecology · 58 citations
https://doi.org/10.1016/j.ajog.2022.06.052
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib
2023 · Nature Communications · 54 citations
https://doi.org/10.1038/s41467-023-40061-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat